{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:21:25Z","timestamp":1761862885253},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,11,23]],"date-time":"2009-11-23T00:00:00Z","timestamp":1258934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,11,23]],"date-time":"2009-11-23T00:00:00Z","timestamp":1258934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1038\/bmt.2009.333","type":"journal-article","created":{"date-parts":[[2009,11,23]],"date-time":"2009-11-23T11:45:28Z","timestamp":1258976728000},"page":"1234-1238","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Consolidation with high-dose chemotherapy and stem cell support for responding patients with metastatic soft tissue sarcomas: prospective, single-institutional phase II study"],"prefix":"10.1038","volume":"45","author":[{"given":"B","family":"Kasper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Scharrenbroich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Wuchter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A D","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Egerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,11,23]]},"reference":[{"key":"BFbmt2009333_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1200\/JCO.1999.17.1.150","volume":"17","author":"M Van Glabbeke","year":"1999","unstructured":"Van Glabbeke M, van Oosterom AT, Oosterhuis JW, Mouridsen H, Crowther D, Somers R et al. Prognostic factors in advanced soft tissue sarcoma: an analysis of 2185 patients treated with anthracycline-containing first-line regimens\u2014A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group study. J Clin Oncol 1999; 17: 150\u2013157.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009333_CR2","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1200\/JCO.1995.13.7.1537","volume":"13","author":"A Santoro","year":"1995","unstructured":"Santoro A, Tursz T, Mouridsen H, Verweij J, Steward W, Somers R et al. Doxorubicin versus CyVADic versus ifosfamide plus doxorubicin in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1995; 13: 1537\u20131545.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009333_CR3","first-page":"517a","volume":"17","author":"NB Bui","year":"1998","unstructured":"Bui NB, Demaille MC, Chevreau C, Blay JY, Cupissol D, Rios M et al. qMAID vs MAID+25% in adults with advanced soft tissue sarcoma (STS): first results of a randomized study of the FNCLCC Sarcoma Group. Proc Am Soc Clin Oncol 1998; 17: 517a (abstract 1991).","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BFbmt2009333_CR4","first-page":"512a","volume":"17","author":"JY Blay","year":"1998","unstructured":"Blay JY, van Glabbeke M, Nielsen OS, van Oosterom AT, Tursz T, Oosterhuis JW et al. Five-year survivors in patients (pts) with advanced soft tissue sarcoma (ASTS) treated with doxorubicin: a study on 1742 patients (STBSG). Proc Am Soc Clin Oncol 1998; 17: 512a (abstract 1973).","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BFbmt2009333_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/1040-8428(94)00146-K","volume":"20","author":"J Verweij","year":"1995","unstructured":"Verweij J, Mouridsen HT, Nielsen OS, Woll PJ, Somers R, van Oosterom AT et al. The present state of the art in chemotherapy for soft tissue sarcomas in adults: The EORTC point of view. Crit Rev Oncol Hematol 1995; 20: 193\u2013201.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BFbmt2009333_CR6","doi-asserted-by":"crossref","unstructured":"Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet 1997; 350: 1647\u20131654.","DOI":"10.1016\/S0140-6736(97)08165-8"},{"key":"BFbmt2009333_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/13577140020008066","volume":"4","author":"VH Bramwell","year":"2000","unstructured":"Bramwell VH, Anderson D, Charette ML . Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft-tissue sarcoma: a meta-analysis and clinical practice guideline. Sarcoma 2000; 4: 103\u2013112.","journal-title":"Sarcoma"},{"key":"BFbmt2009333_CR8","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1200\/JCO.1997.15.6.2378","volume":"15","author":"SR Patel","year":"1997","unstructured":"Patel SR, Vadhan-Raj S, Papadopolous N, Plager C, Burgess MA, Hays C et al. High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies \u2014dose-response and schedule dependence. J Clin Oncol 1997; 15: 2378\u20132384.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009333_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/cncr.23592","volume":"113","author":"N Pervaiz","year":"2008","unstructured":"Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M . A systemic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 2008; 113: 573\u2013581.","journal-title":"Cancer"},{"key":"BFbmt2009333_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ctrv.2008.01.005","volume":"34","author":"S Verma","year":"2008","unstructured":"Verma S, Younus J, Stys-Norman D, Haynes AE, Blackstein M . Members of the Sarcoma Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Meta-analysis of ifosfamide based chemotherapy in advanced soft tissue sarcoma. Cancer Treat Rev 2008; 34: 339\u2013347.","journal-title":"Cancer Treat Rev"},{"key":"BFbmt2009333_CR11","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/S0959-8049(97)00102-0","volume":"33","author":"G Saeter","year":"1997","unstructured":"Saeter G, Alvegard TA, Monge OR, Strander H, Turesson I, Klepp R et al. Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma: a Scandinavian Sarcoma Group phase II study. Eur J Cancer 1997; 33: 1551\u20131558.","journal-title":"Eur J Cancer"},{"key":"BFbmt2009333_CR12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0959-8049(96)00297-3","volume":"33","author":"S Jelic","year":"1997","unstructured":"Jelic S, Kovcin V, Milanovic N, Babovic N, Kreacic M, Ristovic Z et al. Randomised study of high-dose epirubicin versus high-dose epirubicin\u2013cisplatin chemotherapy for advanced soft tissue sarcoma. Eur J Cancer 1997; 33: 220\u2013225.","journal-title":"Eur J Cancer"},{"key":"BFbmt2009333_CR13","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1200\/JCO.1998.16.4.1438","volume":"16","author":"P Reichardt","year":"1998","unstructured":"Reichardt P, Tilgner J, Hohenberger P, Dorken B . Dose-intensive chemotherapy with ifosfamide, epirubicin, and filgrastim for adult patients with metastatic or locally advanced soft tissue sarcoma: a phase II study. J Clin Oncol 1998; 16: 1438\u20131443.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009333_CR14","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/(SICI)1097-0142(19971001)80:7<1221::AID-CNCR4>3.0.CO;2-N","volume":"80","author":"C Bokemeyer","year":"1997","unstructured":"Bokemeyer C, Franzke A, Hartmann JT, Schober C, Arseniev L, Metzner B et al. A phase I\/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas. Cancer 1997; 80: 1221\u20131227.","journal-title":"Cancer"},{"key":"BFbmt2009333_CR15","first-page":"373","volume":"15","author":"AD Elias","year":"1995","unstructured":"Elias AD, Ayash LJ, Wheeler C, Schwartz G, Tepler I, Gonin R et al. Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support. Bone Marrow Transplant 1995; 15: 373\u2013379.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009333_CR16","first-page":"405","volume":"10","author":"C Dumontet","year":"1992","unstructured":"Dumontet C, Biron P, Bouffet E, Blay JY, Meckenstock R, Chauvin F et al. High dose chemotherapy with ABMT in soft tissue sarcomas: a report of 22 cases. Bone Marrow Transplant 1992; 10: 405\u2013408.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009333_CR17","first-page":"960","volume":"194","author":"R Mesia","year":"1994","unstructured":"Mesia R, Sola C, Lopez Pousa A, Mendoza L, Bellet M, Andres L et al. High-dose chemotherapy and autologous bone marrow transplantation in high-grade metastatic sarcomas. Rev Clin Esp 1994; 194: 960\u2013965.","journal-title":"Rev Clin Esp"},{"key":"BFbmt2009333_CR18","first-page":"119","volume":"26","author":"C Seynaeve","year":"1999","unstructured":"Seynaeve C, Verweij J . High-dose chemotherapy in adult sarcomas: no standard yet. Semin Oncol 1999; 26: 119\u2013133.","journal-title":"Semin Oncol"},{"key":"BFbmt2009333_CR19","first-page":"19","volume":"25","author":"AD Elias","year":"1998","unstructured":"Elias AD . High-dose therapy for adult soft tissue sarcoma: dose response and survival. Semin Oncol 1998; 25: 19\u201323 and 45\u201348.","journal-title":"Semin Oncol"},{"key":"BFbmt2009333_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1040-8428(01)00153-6","volume":"41","author":"P Reichardt","year":"2002","unstructured":"Reichardt P . High-dose chemotherapy in adult soft tissue sarcoma. Crit Rev Oncol Hematol 2002; 41: 157\u2013167.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BFbmt2009333_CR21","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1200\/JCO.2000.18.21.3643","volume":"18","author":"JY Blay","year":"2000","unstructured":"Blay JY, Bouhour D, Ray-Coquard I, Dumontet C, Philip T, Biron P . High-dose chemotherapy with autologous hematopoietic stem-cell transplantation for advanced soft tissue sarcoma in adults. J Clin Oncol 2000; 18: 3643\u20133650.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009333_CR22","first-page":"858","volume":"88","author":"I Ray-Coquard","year":"2001","unstructured":"Ray-Coquard I, Biron P, Blay JY . High-dose chemotherapy in soft tissue sarcomas of adults. Bull Cancer 2001; 88: 858\u2013862.","journal-title":"Bull Cancer"},{"key":"BFbmt2009333_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S1040-8428(01)00150-0","volume":"41","author":"G Rosti","year":"2002","unstructured":"Rosti G, Ferrante P, Ledermann J, Leyvraz S, Ladenstein R, Koscileniak E et al. High-dose chemotherapy for solid tumors: results of the EBMT. Crit Rev Oncol Hematol 2002; 41: 129\u2013140.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BFbmt2009333_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000100447","volume":"71","author":"M Schlemmer","year":"2006","unstructured":"Schlemmer M, Wendtner CM, Falk M, Abdel-Rahmen S, Licht T, Baumert J et al. Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomas. Oncology 2006; 71: 32\u201339.","journal-title":"Oncology"},{"key":"BFbmt2009333_CR25","doi-asserted-by":"publisher","first-page":"15S","DOI":"10.1200\/JCO.2008.21.7695","volume":"27","author":"NN Binh","year":"2009","unstructured":"Binh NN, Chevreau C, Penel N, Bay J, Coindre J, Mathoulin-Pelissier S et al. Consolidation with high-dose chemotherapy for responding patients to standard chemotherapy in advanced, metastatic soft tissue sarcoma (STS): a randomized trial from FNCLCC\u2014French Sarcoma Group. J Clin Oncol 2009; 27: 15S (abstract 10505).","journal-title":"J Clin Oncol"},{"key":"BFbmt2009333_CR26","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/S0959-8049(97)00247-5","volume":"33","author":"P Reichardt","year":"1997","unstructured":"Reichardt P, Verweij J, Crowther D . Current controversies in cancer: should high-dose chemotherapy be used in the treatment of soft-tissue sarcoma? Eur J Cancer 1997; 33: 1351\u20131360.","journal-title":"Eur J Cancer"},{"key":"BFbmt2009333_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/sj.bmt.1704520","volume":"34","author":"B Kasper","year":"2004","unstructured":"Kasper B, Lehnert T, Bernd L, Mechtersheimer G, Goldschmidt H, Ho AD et al. High-dose chemotherapy with autologous peripheral blood stem cell transplantation for bone and soft-tissue sarcomas. Bone Marrow Transplant 2004; 34: 37\u201341.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009333_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000085704","volume":"68","author":"B Kasper","year":"2005","unstructured":"Kasper B, Ho AD, Egerer G . Is there an indication for high-dose chemotherapy in the treatment of bone and soft-tissue sarcoma? Oncology 2005; 68: 115\u2013121.","journal-title":"Oncology"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2009333.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2009333","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2009333.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T12:30:44Z","timestamp":1648038644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2009333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,23]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["BFbmt2009333"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2009.333","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,23]]},"assertion":[{"value":"24 August 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}